IL10 and neoplasm: In fact, BRAF inhibitors treatment is associated with decreased production of the immunosuppressive factor IL10 and enhanced expression of tumor-specific antigens [45] and so BRAF inhibitors might induce T-cell infiltration before treatment with immunotherapy.